The S&P 500 would reach 6,666 points by the end of 2025 with earnings per share from S&P 500 member companies to grow by 13 percent next year, according to Savita Subramanian, BofA's chief U.S. equity ...

Seemingly overnight, millions of people were taking the medicines, known as GLP-1s, while blockbuster drugs like Ozempic, Wegovy, Mounjaro, and Zepbound brought in billions for pharma companies, and a ...

Finding an affordable car in the United States has already become a challenge for many budget-constrained Americans, as new import tariffs on Mexican-built vehicles threaten to make the problem worse, ...